Product Information
MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0737 per EA under NDC 72603060501. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on Aug 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603060501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212543FDA Approved
8/19/2019
TE Code
AB
On Market Since
4/21/2025
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 56 times since Sep 10, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0737 per EA |
|---|---|
| All-time high | $0.0740 (Jun 10, 2026) |
| All-time low | $0.0703 (Jul 22, 2026) |
| 52-week high | $0.0740 |
| 52-week low | $0.0703 |
| Median price | $0.0720 |
| Average price | $0.0723 |
| Largest weekly change | +3.6% (Aug 19, 2026) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Midodrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0737 per EA (NDC 72603060501), effective Sep 30, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Sep 10, 2025, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0703 (Jul 22, 2026) to a high of $0.0740 (Jun 10, 2026), with a median of $0.0720 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 72603060501) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.